BATS BZX Real-Time Price
As of 11:30am ET
| -0.42 / -4.25%|
The 8 analysts offering 12-month price forecasts for ARIAD Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 11.00 and a low estimate of 4.50. The median estimate represents a -4.96% decrease from the last price of 9.47.
The current consensus among 9 polled investment analysts is to Hold stock in ARIAD Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.